Search results
YS Biopharma to Hold Extraordinary General Meeting on May 21, 2024 and Announces the Appointment of...
KTLA-TV Los Angeles· 1 day agoYS Biopharma Co., Ltd. (Nasdaq: YS) ("YS Biopharma" or the "Company"), a global biopharmaceutical company dedicated to discovering, developing, manufacturing, and delivering new generations ...
Small Business - Cordele Dispatch | Cordele Dispatch
Cordele Dispatch· 7 days agoIpsen (Euronext: IPN; ADR: IPSEY), a global specialty-driven biopharmaceutical company, announced today the appointment of Keira Driansky as EVP, President of North America, effective May 13 ...
3 Robotics Stocks That Could Be Multibaggers in the Making: Spring Edition
InvestorPlace· 3 days agoWith the market surging, investors looking at this sector could be in line to see impressive upside,...
YS Biopharma to Hold Extraordinary General Meeting on May 21, 2024 and Announces the Appointment of...
StreetInsider· 1 day agoGAITHERSBURG, Md., May 7, 2024 /PRNewswire/ -- YS Biopharma Co., Ltd. (Nasdaq:...
Endo Announces New Peyronie's Disease Data Presented at the American Urological Association Annual...
FOX 23 News Albany· 1 day agoEndo supported development of these data by providing funding through investigator-initiated research grants. "I'm pleased to share new medical knowledge at the AUA annual meeting to help < ...
Sentynl Therapeutics Announces Global Acquisition of Zokinvy® (Lonafarnib) for Treatment of...
WTNH-TV New Haven· 5 days agoSentynl, a Zydus Group company, receives worldwide proprietary rights to Zokinvy, adding to portfolio of biopharmaceuticals for rare and ultra-rare diseases Zokinvy is approved in the U.S. ( ...
NCCN Policy Summit Encourages Conversation and Action on Sexual Health and Fertility Issues Faced by...
Newswise· 3 days agoWASHINGTON, D.C. [May 6, 2024] — The National Comprehensive Cancer Network® (NCCN®)—an alliance of...
3 Growth Stocks You'll Kick Yourself for Not Buying Today
InvestorPlace· 5 days agoGrowth stocks epitomize the attraction of equity investing due to their strong potential and ability to generate substantial returns. When referring to these stocks, those companies with leadership ...
UChicago Medicine invests $730.9 million in community benefits for Chicago’s South Side and south...
Newswise· 7 days agoThe investments —which increased by 6.5% over fiscal 2023 — included $636.6 million through the University of Chicago Medical Center and $94.3 million through UChicago Medicine Ingalls Memorial ...
NCCN Policy Summit Encourages Conversation and Action on Sexual Health and Fertility Issues Faced by...
WJTV Jackson· 2 days agoNational Comprehensive Cancer Network forum examines the impact knowledge gaps, societal stigma, and shifting policies can have on quality of life for people with cancer. WASHINGTON, May 6, ...